Predictive genetic testing and consumer / wellness genomics


New York, June 09, 2021 (GLOBE NEWSWIRE) – The growing awareness of the use of genetic testing and the integration of predictive genetic testing with advanced technology is expected to drive the growth of the market.

Market size – USD 4.5 billion in 2020 Market growth – 14% Market trends – Growing demand for predictive healthcare

The Global predictive genetic testing and consumer / wellness genomics market The size is expected to reach $ 12.8 billion in 2028, registering a CAGR of 14% over the forecast period, according to the latest report from Reports and Data. The main driver of market revenue growth is the increased global awareness of the use of genetic testing. In addition, the growth of pharmaceutical companies involved in genomics research will enhance the market growth opportunities.

Predictive genetic testing is the type of genetic test that predicts the future risk of disease in an asymptomatic person. Genetic testing involves examining DNA and is able to reveal mutations or changes in the genes of living things.

Request a free sample of this research report at: https://www.reportsanddata.com/sample-enquiry-form/4095

The growing awareness of the benefits of predictive genetic testing and the introduction of Next Generation Platform Sequencing (NGS) are expected to accelerate the market growth during the forecast period. Predictive genetic testing helps analyze a genetic disease for better treatment and support.

Growing healthy lifestyle trends and growing healthcare awareness programs have created the demand for predictive genetic testing and consumer / wellness genomics. Genetic testing helps predict future risk of disease and offers information and data about a child’s genetic makeup. In addition, the tests are effective for people with a history of genetic disorders. For example, a global study from the Mayo Clinic in the United States found that one in ten people who opted for predictive genetic testing realized they were at hereditary risk for a condition that could be cured with drugs. preventive care.

However, the high cost of genomic research equipment and the complexity of predictive genetic testing and consumer / welfare genomics are major factors which may restrain the market to some extent in the future. Moreover, the lack of qualified professionals and inadequate financing are expected to create new challenges for the growth of the market.

To identify key industry trends, click on the link below: https://www.reportsanddata.com/report-detail/predictive-genetic-testing-and-consumer-wellness-genomics-market

Some highlights of the report:

  • The predictive genetic testing segment accounted for the largest share of the global market revenue in 2020.
  • Breast and Ovarian Cancer Based Predictive Testing segment is expected to register a significant CAGR during the forecast period due to the increasing prevalence of ovarian and breast cancer worldwide.
  • The Direct To Consumer (DTC) segment is expected to hold the largest market share during the forecast period due to the growing awareness related to DTP genetic testing.
  • The North America region is expected to account for the largest share of revenue over the forecast period due to robust healthcare infrastructure.
  • The revenue of the predictive genetic testing and consumer genomics / welfare genomics market in Asia-Pacific is expected to grow at a considerably high rate owing to favorable government and private investments in pharmaceutical R&D related to genomics.

Segments covered in the report:

For the purpose of this report, Reports and Data has segmented the global predictive genetic testing and consumer / wellness genomics market on the basis of type, application, parameter type, and region:

Type Outlook (Revenue, billion USD; 2018 – 2028)

  • Predictive tests
  • Consumer genomics
  • Genomics of well-being

Application Outlook (Revenue, USD Billion; 2018 – 2028)

  • Predictive genetic testing and consumer genomics
    • Diabetes screening and surveillance
    • Colon Cancer
    • Breast and ovarian cancer
    • Urological screening / Prostate cancer screening
    • Cardiovascular screening
    • Parkinsonism / Alzheimer’s disease
    • Orthopedic and musculoskeletal
    • Other cancer screening
    • Other diseases
    • Skin genetics and metabolism
    • Nutria Genetics
    • Other

Parameter type Outlook (Revenue, billion USD; 2018 – 2028)

  • Clinical
  • Direct to consumer
  • Hospital

Regional outlook (revenue, billion USD; 2018 – 2028)

  • North America
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • The rest of europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • South Africa
    • Rest of Middle East and Africa

Browse similar research reports:

Hepatitis Diagnostic Testing Market Size, Share and Trend Analysis Report, by diagnostic tests (blood tests {liver function tests, immunoassays and nucleic acid tests}, imaging tests, liver biopsy), by end user (hospitals , clinics, research institutes, diagnostic laboratories, others) and by region Forecast until 2028

Sample Validity Testing Market Size, Sharing and analysis, by product and services (products (reagents, calibrators and controls, assay kits, disposables), services), by type (laboratory tests, rapid tests / POC), by end use (workplaces, drug testing laboratories, law enforcement agencies, pain management centers, drug addiction treatment centers, others) and by region, forecast to 2028

Primary Care POC Diagnostics Market Size, Sharing and analysis, by product (glucose tests, Hb1Ac tests, coagulation tests, fertility tests, thyroid tests, hematology tests, lipid tests, etc.), by end use (pharmacy and retail clinics at retail, doctor’s office, emergency care clinics and others) Others), and by region, forecast to 2028

Ovarian Cancer Diagnostics Market Size, Sharing and analysis, by type of cancer (epithelial tumor, germ cell tumor, stromal cell tumor, others), by type of diagnosis (biopsy, blood test, imaging and others), by end use (hospital laboratories, cancer diagnosis, research institutes, others) and by region, global forecasts up to 2028

About reports and data

Reports and Data is a market research and consulting company that provides syndicated research reports, custom research reports, and consulting services. Our solutions focus uniquely on your goal to locate, target and analyze changes in consumer behavior across demographics, across industries and help customers make smarter business decisions. We offer market intelligence studies ensuring relevant and factual research across many industries including healthcare, technology, chemicals, power and energy. We are constantly updating our research offerings to ensure that our clients are up to date with the latest trends that exist in the market. Reports and Data has a solid base of experienced analysts from various fields of expertise.

Contact us:

John W

Head of Business Development

Reports and Data | The Web: www.reportsanddata.com

Direct line: + 1-212-710-1370

E-mail: [email protected]

Read the full press release: https://www.reportsanddata.com/report-detail/predictive-genetic-testing-and-consumer-wellness-genomics-market



Source link

Comments are closed.